Third phase of serosurvey to identify COVID-19 antibodies under way

July 07, 2021 07:44 pm | Updated 07:44 pm IST - TIRUCHI

Health officials in the district have undertaken the third round of serological surveillance to determine the development of antibodies against COVID-19 among the people. The exercise, undertaken across the State, would help in indicating herd immunity, officials said.

Herd immunity is a form of protection from an infection that can occur when over half of a population is immune to it, either through vaccination or from getting infected, M. Yazhini, City Health Officer told The Hindu .

The Directorate of Public Health would study the incidence of infection, identify hotspots and inform local health officials, who would take blood samples to test for antibodies for COVID-19. In Tiruchi city, eight such locations have been identified.

“We took 30 samples from each location. So, 30 samples of 30 different individuals in 30 adjacent houses,” Dr. Yazhini said.

Residents who were unwilling to take part or unavailable were skipped. The localities identified were different from those surveyed in the previous two rounds. The samples are sent to a laboratory of the DPH to test for antibodies. “Our nearest lab is in Manapparai, and samples from over six districts have been submitted there for processing,” she said.

In the first serosurvey, they found 30% of the population with antibodies, while in the second, which was between the first and the second, it was around 27%. “This time around, we are expecting at least 40%,” she said.

The vaccination drive, which has picked up pace in the district, would contribute to the population with antibodies. “We can soon reach over 50% and achieve herd immunity, protecting us from future waves of COVID-19,” she added.

A similar exercise is also being undertaken in rural parts of the district, where 27 hotspots have been identified. Once all the samples are submitted, results of the serosurvey could be expected within 10 days.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.